AxoGen, Inc. (AXGN) Investor Relations Documents

AxoGen, Inc. (AXGN) investor relations documents from the company's IR site: 6 presentations, 34 press releases; latest deck 2026-07-29. Read in-app with summaries. First-party data.

Q2 2026 Financial Results Presentation — Q2 2026 results show $69.7M revenue (+23.1% YoY) and $8.4M Adjusted EBITDA. Full-year 2026 guidance projects at least 24% revenue growth and 73% gross margin.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-29Press releaseAxogen, Inc. Reports Second Quarter 2026 Financial Results
2026-07-29Earnings deckQ2 2026 Financial Results Presentation
2026-07-15Press releaseAxogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 Read Press Release
2026-04-30Press releaseAxogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
2026-04-28Press releaseAxogen, Inc. Reports First Quarter 2026 Financial Results
2026-04-28Earnings deckQ1 2026 Financial Results Presentation
2026-04-28Press releasePDF
2026-04-27PresentationCorporate Presentation
2026-04-14Press releaseAxogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026
2026-02-24Earnings deckPresentationPDF
2026-02-24Press releaseAxogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-02-17Press releaseAxogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2026-02-10Press releaseAxogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
2026-01-21Press releaseAxogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
2026-01-21Press releaseAxogen Announces Proposed Public Offering of Common Stock
2026-01-12Press releaseAxogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
2025-10-29PresentationPresentationPDF
2025-03-04PresentationAnalyst & Investor Day Presentation
2025-02-25Press releaseAxogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
2025-02-11Press releaseAxogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
2025-01-10Press releaseAxogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
2024-11-07Press releaseAxogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
2024-10-24Press releaseAxogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
2024-08-08Press releaseAxogen, Inc. Reports Second Quarter 2024 Financial Results
2024-07-23Press releaseAxogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
2024-05-02Press releaseAxogen, Inc Reports First Quarter 2024 Financial Results
2024-03-05Press releaseAxogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
2024-01-04Press releaseAxogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
2023-11-07Press releaseAxogen, Inc. Reports 2023 Third Quarter Financial Results
2023-08-07Press releaseAxogen, Inc. Reports 2023 Second Quarter Financial Results
2023-05-09Press releaseAxogen, Inc. Reports 2023 First Quarter Financial Results
2023-03-14Press releaseAxogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results
2022-11-08Press releaseAxogen, Inc Reports 2022 Third Quarter Financial Results
2022-08-03Press releaseEarnings ReleaseHTML
2022-05-04Press releaseEarnings ReleaseHTML
2022-02-22Press releaseEarnings ReleaseHTML
2021-11-03Press releaseEarnings ReleaseHTML
2021-08-04Press releaseEarnings ReleaseHTML
2021-05-05Press releaseEarnings ReleaseHTML
2021-02-22Press releaseEarnings ReleaseHTML

AXGN overview · AXGN earnings · AXGN financials · AXGN KPIs · AXGN ownership · AXGN peers · AXGN filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.